We have located links that may give you full text access.
THE USE OF RADIOFREQUENCY NEUROABLATION IN THE TREATMENT OF OMALGIA IN PATIENTS WITH SHOULDER JOINT ARTHROSIS.
Georgian Medical News 2023 Februrary
The aim of the study was to evaluate the effectiveness of radiofrequency denervation (neuroablation) of the suprascapular nerve in the treatment process of omalgia in patients with degenerative and dystrophic disorders of the shoulder joint. 31 patients (31 joints were researched) took the treatment and analyzed their data in the rehabilitation department of the State Institution "Institute of Traumatology and Orthopedics of the National Academy of Medical Sciences of Ukraine" from 2019 to 2021. X-ray assessment was performed to find out the stage of the disease according to the classification of M. Lequesne Kellgren and J. Lawrence. All patients had radiofrequency neuroablation of the suprascapular nerve. Patients were assessed before the RFN procedure, after 1, 3, 6, and 12 months after the procedure. Due to performed treatment, the average VAS score for pain was 7,65±1,23 cm. A decrease in pain level by 3 cm or more was considered reliable. 1 month after suprascapular nerve RFN we had a significant decrease in pain syndrome according to VAS in the group of patients within 3,87±1,06 cm (p<0,05); after 3 months a stable positive remained at the 3,1±1,42 cm; after 6 months began to gradually deteriorate to 5,52±1,24 cm and remained after 12 months at the 5,2±1,58 cm. Thus, the suprascapular nerve RFN procedure allows for maintaining a stable positive result for 6 months with subsequent deterioration. After 12 months abandoned the use of NSAIDs - 29,03% of patients and continued to additionally use NSAIDs for pain relief sometimes or constantly almost 64,52% of the group examined. The results of our studies complement those of Taverner et al., Eyigor et al., indicating a trend toward a decrease in pain and functional limitations among patients with omalgia after the RFN procedure, and the preservation of the effect during the follow-up year after the procedure. The suprascapular nerve RFN procedure makes it possible to reduce the level of pain syndrome and refuse the use of painkillers in patients with shoulder joint arthrosis in almost 30-40% of cases, and the effect of pain relief lasts from 6 to 12 months in most cases.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app